1. Home
  2. TELA vs RMCO Comparison

TELA vs RMCO Comparison

Compare TELA & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELA
  • RMCO
  • Stock Information
  • Founded
  • TELA 2012
  • RMCO 2021
  • Country
  • TELA United States
  • RMCO United States
  • Employees
  • TELA N/A
  • RMCO N/A
  • Industry
  • TELA Medical/Dental Instruments
  • RMCO Multi-Sector Companies
  • Sector
  • TELA Health Care
  • RMCO Miscellaneous
  • Exchange
  • TELA Nasdaq
  • RMCO Nasdaq
  • Market Cap
  • TELA 47.1M
  • RMCO 45.7M
  • IPO Year
  • TELA 2019
  • RMCO N/A
  • Fundamental
  • Price
  • TELA $1.15
  • RMCO $2.16
  • Analyst Decision
  • TELA Buy
  • RMCO Buy
  • Analyst Count
  • TELA 3
  • RMCO 1
  • Target Price
  • TELA $3.42
  • RMCO N/A
  • AVG Volume (30 Days)
  • TELA 313.6K
  • RMCO 78.6K
  • Earning Date
  • TELA 11-13-2025
  • RMCO 11-13-2025
  • Dividend Yield
  • TELA N/A
  • RMCO 0.45%
  • EPS Growth
  • TELA N/A
  • RMCO N/A
  • EPS
  • TELA N/A
  • RMCO N/A
  • Revenue
  • TELA $77,055,000.00
  • RMCO $3,798,352.00
  • Revenue This Year
  • TELA $25.72
  • RMCO $6,850.91
  • Revenue Next Year
  • TELA $22.03
  • RMCO $20.00
  • P/E Ratio
  • TELA N/A
  • RMCO N/A
  • Revenue Growth
  • TELA 12.24
  • RMCO 445.90
  • 52 Week Low
  • TELA $0.86
  • RMCO $0.90
  • 52 Week High
  • TELA $3.20
  • RMCO $4.76
  • Technical
  • Relative Strength Index (RSI)
  • TELA 44.20
  • RMCO 37.97
  • Support Level
  • TELA $1.01
  • RMCO $2.83
  • Resistance Level
  • TELA $1.25
  • RMCO $3.26
  • Average True Range (ATR)
  • TELA 0.13
  • RMCO 0.40
  • MACD
  • TELA 0.01
  • RMCO -0.13
  • Stochastic Oscillator
  • TELA 57.50
  • RMCO 17.41

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

About RMCO Royalty Management Holding Corporation

Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.

Share on Social Networks: